Edition:
United States

C R Bard Inc (BCR.N)

BCR.N on New York Stock Exchange

308.70USD
26 May 2017
Change (% chg)

$0.11 (+0.04%)
Prev Close
$308.59
Open
$308.40
Day's High
$308.87
Day's Low
$307.97
Volume
74,520
Avg. Vol
218,812
52-wk High
$309.16
52-wk Low
$203.63

Latest Key Developments (Source: Significant Developments)

Becton Dickinson, in connection with termination of merger, Bard must pay termination fee of $750 mln
Monday, 24 Apr 2017 07:47am EDT 

April 24 (Reuters) - Becton Dickinson and Co ::Becton Dickinson -in connection with termination of merger agreement under specified circumstances, Bard is required to pay co termination fee of $750 million.  Full Article

Becton Dickinson to buy Bard for $24 billion
Sunday, 23 Apr 2017 05:04pm EDT 

April 24 (Reuters) - C R Bard Inc :BD to acquire Bard for $24 billion.Deal immediately accretive and expected to generate high single-digit accretion to adjusted EPS in fiscal year 2019 to Becton Dickinson .BD will acquire Bard for $317.00 per bard common share in cash and stock.Agreement has been unanimously approved by boards of directors of both companies.Approximately $300 million of estimated annual, pre-tax, run-rate cost synergies are expected by fiscal year 2020 for Becton Dickinson .BD also expects to benefit from revenue synergies beginning in fiscal year 2019.Transaction is expected to improve BD's gross margins by approximately 300 basis points in fiscal year 2018.Deal expected to increase BD's earnings per share growth trajectory to mid-teens, and generate strong cash flow.Bd expects to contribute approximately $1.7 billion of available cash to fund transaction.BD also expects to fund deal with about $10 billion of new debt and about $4.5 billion of equity and equity linked securities.At deal closing, Bard shareholders will own approximately 15 percent of combined company.Bard shareholders will also receive $8 billion of BD common stock.  Full Article

C R Bard Q4 earnings per share $2.11
Thursday, 26 Jan 2017 04:15pm EST 

C R Bard Inc : Bard announces fourth quarter results . Q4 earnings per share $2.11 . Q4 sales $967.1 million versus I/B/E/S view $955.5 million . Q4 earnings per share view $2.74 -- Thomson Reuters I/B/E/S . Q4 adjusted earnings per share $2.77 . Sees FY 2017 sales up 4 to 5 percent . Sees FY 2017 adjusted earnings per share $11.45 to $11.75 . For full year 2017, net sales are forecasted to increase between 4 percent and 5 percent on an as-reported basis . FY2017 earnings per share view $11.40, revenue view $3.90 billion -- Thomson Reuters I/B/E/S . Excluding impact of foreign exchange, full year 2017 net sales are forecasted to increase between 6 percent and 6.5 percent .C R Bard-sees FY 2017 adjusted EPS to be between $11.45 and $11.75.  Full Article

Bard announces second quarter results
Tuesday, 26 Jul 2016 04:15pm EDT 

C R Bard Inc : Sees FY 2016 adjusted earnings per share $10.10 to $10.20 . Bard announces second quarter results . Q2 earnings per share $2.11 . Sees FY 2016 sales up 7 to 8 percent . Q2 sales $931.5 million versus i/b/e/s view $915.2 million . Q2 earnings per share view $2.47 -- Thomson Reuters I/B/E/S .FY2016 earnings per share view $10.15, revenue view $3.65 billion -- Thomson Reuters I/B/E/S.  Full Article

Bard announces $500 mln share repurchase authorization
Wednesday, 8 Jun 2016 04:15pm EDT 

C R Bard Inc: Bard announces $500 million share repurchase authorization .Buyback is in addition to approximately $205 million remaining under prior authorization announced in J2015.  Full Article

C R Bard Inc Declares Quarterly Dividend
Wednesday, 9 Dec 2015 04:30pm EST 

C R Bard Inc:Declared a regular quarterly dividend of 24 cents per share on Bard's common stock.current indicated annual dividend rate is 96 cents per share.dividend is payable on February 5, 2016 to shareholders of record at the close of business on January 25, 2016.  Full Article

C R Bard Inc agrees to acquire Liberator Medical
Friday, 20 Nov 2015 07:27am EST 

C R Bard Inc:Has entered into a definitive agreement to acquire Liberator Medical Holdings Inc for $3.35 per share, or approximately $181 million.Expects the transaction to close in the first quarter of 2016.  Full Article

C R Bard Inc declares quarterly dividend
Wednesday, 14 Oct 2015 04:15pm EDT 

C R Bard Inc:Declared a regular quarterly dividend of 24 cents per share on Bard's common stock.Says current indicated annual dividend rate is 96 cents per share.Says payable on November 6, 2015 to shareholders of record at the close of business on October 26, 2015.  Full Article

C R Bard Inc agrees to acquire full ownership of its joint venture in Japan
Wednesday, 30 Sep 2015 08:35am EDT 

C R Bard Inc:Bard agrees to acquire full ownership of its joint venture in Japan.Company expects the transaction to add approximately $40 million to 2016 net sales.As consideration for the transaction, Kobayashi will receive 3 billion yen at closing.Entered into a definitive agreement to acquire Kobayashi Pharmaceutical Co. ltd.'s 50% ownership share in medicon, inc.Says transaction has been approved by each company's board of directors and is subject to customary closing conditions.On an operational basis,expects deal to be neutral to adjusted cash EPS both in fourth quarter of 2015 and the full-year 2016.Expects transaction to reduce Q4 and full year 2016 adjusted cash earnings per share by approximately 5 cents and 20 cents respectively.Kobayashi will also receive additional payments annually on the anniversary date of transaction.Including milestone payments, the total deal consideration is 11.2 billion yen.  Full Article

C R Bard Inc raises FY 2015 EPS guidance - conference call
Thursday, 23 Jul 2015 05:00pm EDT 

C R Bard Inc:Says that for FY 2015, it is increasing adjusted EPS guidance by $0.05 to a range of $9 to $9.10.  Full Article

More From Around the Web

BRIEF-Becton Dickinson and Co entered into a three-year term loan agreement

* On May 12, 2017, Becton Dickinson and Company entered into a three-year term loan agreement - SEC filing